Connect
MJA
MJA

Glycaemic control apps for diabetes: lifting the lid

Rahul Barmanray and Esther Briganti
Med J Aust 2018; 209 (10): 426-427. || doi: 10.5694/mja18.00066
Published online: 30 July 2018

The rapidly expanding diabetes app market presents new challenges for patients, health care providers and regulators

The medical technology industry’s explosive growth has set the stage for medical mobile applications (apps) to assist with the management of many chronic diseases. Diabetes mellitus is the archetypal example: its management requires optimising diet, physical activity, blood glucose self-monitoring, and safe medication use. As a multifaceted condition affecting so many people, diabetes is the perfect target for developers of medical apps to realise the promise of the digital revolution.

  • Rahul Barmanray1
  • Esther Briganti2

  • 1 Royal Melbourne Hospital, Melbourne, VIC
  • 2 Monash University, Melbourne, VIC

Correspondence: rahul.barmanray@mh.org.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.